Tag: Glatiramer acetate (Copaxone)

Phase III trial shows survival benefit for early multiple myeloma

Glatiramer acetate (Copaxone) therapy may alter B cell function in multiple sclerosis

byAshley Aaroeand1 others

September 30, 2014

1. Glatiramer acetate is an immunomodulatory drug used in the treatment of multiple sclerosis. 2. Glatiramer acetate appears to alter ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Daraxonrasib extends survival in metastatic pancreatic cancer
Artificial intelligence (AI) scribes showed mixed effects on documentation time and improvements in physician well-being
A lower threshold for referral to the emergency department for outpatient hyperkalemia may reduce mortality

No Result

View All Result

Tag: Glatiramer acetate (Copaxone)

Glatiramer acetate (Copaxone) therapy may alter B cell function in multiple sclerosis

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits